1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Interventional Pulmonology Market
2.2. Global Interventional Pulmonology Market, By Procedure, 2023 (US$ Million)
2.3. Global Interventional Pulmonology Market, By Geography, 2023 (US$ Million)
2.4. Attractive Investment Proposition by Geography, 2023

3. Interventional Pulmonology Market: Competitive Analysis
3.1. Market Positioning of Key Interventional Pulmonology Market Vendors
3.2. Strategies Adopted by Interventional Pulmonology Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032

4. Interventional Pulmonology Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Interventional Pulmonology Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Flexible Bronchoscopy
5.3.2. Rigid Bronchoscopy
5.3.3. Bronchoalveolar Lavage
5.3.4. Lung Biopsy
5.3.5. Bronchial Stent
5.3.6. Balloon Bronchoplasty
5.3.7. Pleuroscopy
5.3.8. Others


6. North America Interventional Pulmonology Market, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)
6.3.Interventional Pulmonology Market: By Region, 2022-2032, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)

7. UK and European Union Interventional Pulmonology Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)
7.3.Interventional Pulmonology Market: By Region, 2022-2032, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)
7.3.1.5. France
7.3.1.5.1. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)

8. Asia Pacific Interventional Pulmonology Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)
8.3.Interventional Pulmonology Market: By Region, 2022-2032, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)
8.3.1.3. India
8.3.1.3.1. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)

9. Latin America Interventional Pulmonology Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)
9.3.Interventional Pulmonology Market: By Region, 2022-2032, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)

10. Middle East and Africa Interventional Pulmonology Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)
10.3.Interventional Pulmonology Market: By Region, 2022-2032, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Interventional Pulmonology Market: By Procedure, 2022-2032, USD (Million)

11. Company Profile
11.1. Boston Scientific Corporation
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. BTG, plc.
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Ethicon, Inc.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. ENDO-FLEX GmbH.
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. HealthTronics, Inc.
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. Karl Storz
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. Medtronic, plc.
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. Pulmonx, Inc.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. Terumo Corporation
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives
11.10. Varian Medical Systems, Inc.
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Portfolio
11.10.4. Strategic Initiatives